BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chavarot N, Morel A, Leruez-Ville M, Vilain E, Divard G, Burger C, Serris A, Sberro-Soussan R, Martinez F, Amrouche L, Bererhi L, Lanternier F, Legendre C, Zuber J, Anglicheau D, Scemla A. Weak antibody response to three doses of mRNA vaccine in kidney transplant recipients treated with belatacept. Am J Transplant 2021. [PMID: 34431207 DOI: 10.1111/ajt.16814] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 33.0] [Reference Citation Analysis]
Number Citing Articles
1 Babel N, Hugo C, Westhoff TH. Vaccination in patients with kidney failure: lessons from COVID-19. Nat Rev Nephrol 2022. [PMID: 35999285 DOI: 10.1038/s41581-022-00617-5] [Reference Citation Analysis]
2 Sakuraba A, Luna A, Micic D. A Systematic Review and Meta-Analysis of Serologic Response following Coronavirus Disease 2019 (COVID-19) Vaccination in Solid Organ Transplant Recipients. Viruses 2022;14:1822. [PMID: 36016444 DOI: 10.3390/v14081822] [Reference Citation Analysis]
3 Morena L, Al Jurdi A, Azzi J, Fishman J, Riella LV. Factors associated with reduced anti-SARS-CoV-2 antibody responses after mRNA vaccination in kidney transplant recipients on belatacept. Kidney Int Rep 2022. [PMID: 35968509 DOI: 10.1016/j.ekir.2022.08.001] [Reference Citation Analysis]
4 Mehrabi Nejad MM, Shobeiri P, Dehghanbanadaki H, Tabary M, Aryannejad A, Haji Ghadery A, Shabani M, Moosaie F, SeyedAlinaghi S, Rezaei N. Seroconversion following the first, second, and third dose of SARS-CoV-2 vaccines in immunocompromised population: a systematic review and meta-analysis. Virol J 2022;19:132. [PMID: 35941646 DOI: 10.1186/s12985-022-01858-3] [Reference Citation Analysis]
5 Noble J, Jouve T, Malvezzi P, Rostaing L. Desensitization in Crossmatch-positive Kidney Transplant Candidates. Transplantation 2022. [PMID: 35939390 DOI: 10.1097/TP.0000000000004279] [Reference Citation Analysis]
6 Chong AS, Habal MV. From bench to bedside: reversing established antibody responses and desensitization. Curr Opin Organ Transplant 2022. [PMID: 35950890 DOI: 10.1097/MOT.0000000000001009] [Reference Citation Analysis]
7 Safa K, Kotton CN. Navigating the unknown: the coronavirus disease 2019 pandemic and solid organ transplantation. Curr Opin Infect Dis 2022;35:288-94. [PMID: 35849518 DOI: 10.1097/QCO.0000000000000852] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Cassaniti I, Gregorini M, Bergami F, Arena F, Sammartino JC, Percivalle E, Soleymaninejadian E, Abelli M, Ticozzelli E, Nocco A, Minero F, Pattonieri EF, Lilleri D, Rampino T, Baldanti F. Effect of a Third Dose of SARS-CoV-2 mRNA BNT162b2 Vaccine on Humoral and Cellular Responses and Serum Anti-HLA Antibodies in Kidney Transplant Recipients. Vaccines (Basel) 2022;10:921. [PMID: 35746528 DOI: 10.3390/vaccines10060921] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Letellier T, Kervella D, Sadek A, Masset C, Garandeau C, Fourgeux C, Gourain V, Poschmann J, Blancho G, Ville S; on behalf of the Divat Consortium. Time-Limited Therapy with Belatacept in Kidney Transplant Recipients. JCM 2022;11:3229. [DOI: 10.3390/jcm11113229] [Reference Citation Analysis]
10 Osmanodja B, Ronicke S, Budde K, Jens A, Hammett C, Koch N, Seelow E, Waiser J, Zukunft B, Bachmann F, Choi M, Weber U, Eberspächer B, Hofmann J, Grunow F, Mikhailov M, Liefeldt L, Eckardt KU, Halleck F, Schrezenmeier E. Serological Response to Three, Four and Five Doses of SARS-CoV-2 Vaccine in Kidney Transplant Recipients. J Clin Med 2022;11:2565. [PMID: 35566691 DOI: 10.3390/jcm11092565] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 11.0] [Reference Citation Analysis]
11 Moreno NF, Mcadams R, Goss JA, Galvan NTN. COVID-19 Vaccine Efficacy and Immunogenicity in End-Stage Renal Disease Patients and Kidney Transplant Recipients. Curr Transpl Rep. [DOI: 10.1007/s40472-022-00366-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Nimmo A, Gardiner D, Ushiro-lumb I, Ravanan R, Forsythe JLR. The Global Impact of COVID-19 on Solid Organ Transplantation: Two Years Into a Pandemic. Transplantation 2022;Publish Ahead of Print. [DOI: 10.1097/tp.0000000000004151] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
13 Baron F, Canti L, Ariën KK, Kemlin D, Desombere I, Gerbaux M, Pannus P, Beguin Y, Marchant A, Humblet-baron S. Insights From Early Clinical Trials Assessing Response to mRNA SARS-CoV-2 Vaccination in Immunocompromised Patients. Front Immunol 2022;13:827242. [DOI: 10.3389/fimmu.2022.827242] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Benning L, Klein K, Morath C, Bartenschlager M, Kim H, Buylaert M, Reineke M, Töllner M, Nusshag C, Kälble F, Reichel P, Schnitzler P, Zeier M, Süsal C, Bartenschlager R, Schaier M, Speer C. Neutralizing Antibody Activity Against the B.1.617.2 (delta) Variant Before and After a Third BNT162b2 Vaccine Dose in Hemodialysis Patients. Front Immunol 2022;13:840136. [DOI: 10.3389/fimmu.2022.840136] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
15 Lee ARYB, Wong SY, Chai LYA, Lee SC, Lee MX, Muthiah MD, Tay SH, Teo CB, Tan BKJ, Chan YH, Sundar R, Soon YY. Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis. BMJ 2022;376:e068632. [PMID: 35236664 DOI: 10.1136/bmj-2021-068632] [Cited by in Crossref: 40] [Cited by in F6Publishing: 22] [Article Influence: 40.0] [Reference Citation Analysis]
16 Gueguen J, Colosio C, Del Bello A, Scemla A, N’guyen Y, Rouzaud C, Carvalho-schneider C, Vargas GG, Tremolières P, Eddine AJ, Masset C, Thaunat O, Chabannes M, Malvezzi P, Pommerolle P, Couzi L, Kamar N, Caillard S, Gatault P. Early administration of Anti-SARS-CoV-2 Monoclonal Antibodies prevents severe Covid-19 in Kidney Transplant Patients. Kidney International Reports 2022. [DOI: 10.1016/j.ekir.2022.03.020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
17 Abravanel F, Marion O, Del Bello A, Beunon T, Romieu-mourez R, Couat C, Pucelle M, Staes L, Guitard J, Esposito L, Faguer S, Kamar N, Izopet J. Humoral and Cellular Immune Responses of Solid Organ Transplant Patients on Belatacept to Three Doses of mRNA-Based Anti-SARS-CoV-2 Vaccine. Vaccines 2022;10:354. [DOI: 10.3390/vaccines10030354] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
18 Kountouras J, Gialamprinou D, Kotronis G, Papaefthymiou A, Economidou E, Soteriades ES, Vardaka E, Chatzopoulos D, Tzitiridou-chatzopoulou M, Papazoglou DD, Doulberis M. Ofeleein i mi Vlaptin—Volume II: Immunity Following Infection or mRNA Vaccination, Drug Therapies and Non-Pharmacological Management at Post-Two Years SARS-CoV-2 Pandemic. Medicina 2022;58:309. [DOI: 10.3390/medicina58020309] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Devresse A, De Greef J, Yombi JC, Belkhir L, Goffin E, Kanaan N. Immunosuppression and SARS-CoV-2 Infection in Kidney Transplant Recipients. Transplantation Direct 2022;8:e1292. [DOI: 10.1097/txd.0000000000001292] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
20 Dulek DE, Ardura MI, Green M, Michaels MG, Chaudhuri A, Vasquez L, Danziger-Isakov L, Posfay-Barbe KM, McCulloch MI, L'Huillier AG, Benden C. Update on COVID-19 vaccination in pediatric solid organ transplant recipients. Pediatr Transplant 2022;:e14235. [PMID: 35060251 DOI: 10.1111/petr.14235] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Du L, Yang Y, Zhang X, Li F. Recent advances in nanotechnology-based COVID-19 vaccines and therapeutic antibodies. Nanoscale 2022. [PMID: 35018939 DOI: 10.1039/d1nr03831a] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
22 Efros O, Anteby R, Halfon M, Meisel E, Klang E, Soffer S. Efficacy and Safety of Third Dose of the COVID-19 Vaccine among Solid Organ Transplant Recipients: A Systemic Review and Meta-Analysis. Vaccines (Basel) 2022;10:95. [PMID: 35062756 DOI: 10.3390/vaccines10010095] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 12.0] [Reference Citation Analysis]
23 Almaghrabi RS, Alhamlan FS, Dada A, Al-Tawfiq JA, Al Hroub MK, Saeedi MF, Alamri M, Alhothaly B, Alqasabi A, Al-Qahtani AA, Al-Omari A, Alshukairi AN. Outcome of SARS-CoV-2 variant breakthrough infection in fully immunized solid organ transplant recipients. J Infect Public Health 2022;15:51-5. [PMID: 34906898 DOI: 10.1016/j.jiph.2021.11.021] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
24 Masset C, Ville S, Garandeau C, Le Borgne F, Letellier T, Cantarovich D, Meurette A, Guillot-Gueguen C, Bentoumi-Loaec M, Giral M, Dantal J, Blancho G. Observations on improving COVID-19 vaccination responses in kidney transplant recipients: heterologous vaccination and immunosuppression modulation. Kidney Int 2021:S0085-2538(21)01136-4. [PMID: 34890687 DOI: 10.1016/j.kint.2021.11.024] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 9.0] [Reference Citation Analysis]
25 Terrec F, Jouve T, Malvezzi P, Janbon B, Naciri Bennani H, Rostaing L, Noble J. Belatacept Use after Kidney Transplantation and Its Effects on Risk of Infection and COVID-19 Vaccine Response. J Clin Med 2021;10:5159. [PMID: 34768680 DOI: 10.3390/jcm10215159] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]